RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancerJohan Staaf, Johan Vallon‐Christersson, Bjørn Naume et al.|npj Breast Cancer|2022Cited by 103
Agreement between molecular subtyping and surrogate subtype classification: a contemporary population-based study of ER-positive/HER2-negative primary breast cancerChristine Lundgren, Maria Ekholm, Pär‐Ola Bendahl et al.|Breast Cancer Research and Treatment|2019Cited by 33
RNA Sequencing-Based Single Sample Predictors of Molecular Subtype and Risk of Recurrence for Clinical Assessment of Early-Stage Breast CancerJohan Staaf, Johan Vallon‐Christersson, Jari Häkkinen et al.|medRxiv|2021Cited by 6
Abstract OT2-30-01: Nordictrip, a translational randomized phase-3study exploring the effect of the addition of capecitabine to carboplatinum-based chemotherapy in early “triple negative” breast cancer, ClinicalTrials.gov Identifier: NCT04335669Niklas Loman, Henrik Lindman, Barbro Linderholm et al.|Cancer Research|2022Cited by 0